...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Prescribing trends of anti glaucoma medication usage in treatment naive patients of primary open angle glaucoma in a tertiary care hospital in Eastern India
【24h】

Prescribing trends of anti glaucoma medication usage in treatment naive patients of primary open angle glaucoma in a tertiary care hospital in Eastern India

机译:在印度东部一家三级护理医院中,针对未治疗的原发性开角型青光眼患者的抗青光眼药物使用趋势

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Primary open angle glaucoma remains a high magnitude healthcare problem due to its prevalence and chronicity. The real world scenario of anti glaucoma medical therapy needs periodical auditing as far as drug prescriptions are concerned for formulation of treatment guidelines. Few studies from India have taken a longitudinal approach in this respect. This study was undertaken to identify such lacunae. Methods: This was an open label, prospective, observational study. Each treatment naive patient was followed up for a period of 6 months, where their prescriptions were scanned for the type of the anti glaucoma medications, total number of medications, route of administration, their duration of use and their frequency of dosage and change in medications if any, in each visits. Results: A gradual shift from monotherapy towards combination therapy was observed. Overall averages for prescriptions were topped by monotherapy at 44.25 followed by fixed dose combinations at 38.25, and then combination-polytherapy at 36 and the least number of prescriptions were for concurrent polytherapy at 17.5. Amongst all monotherapy agents, beta blockers were the most frequently prescribed drugs at baseline but their share of prescriptions was almost halved at the end of our study. The prostaglandin analogs on the other hand saw an upsurge in prescriptions from their baseline to the end of this study. Prostaglandin analogs andbeta blockers as fixed dose combination was a popular prescription over the entire study duration. Conclusions: Prescribing trends were remarkable for the shift from primary monotherapy towards fixed dose combinations as the study concluded. The decline in the number of beta blocker prescriptions and a rise in prostaglandin analog prescriptions is a testament to their better effectiveness and tolerability. The future of open angle glaucoma pharmacotherapy lies in prescribing more efficacious drugs either in monotherapy or in fixed combinations.
机译:背景:原发性开角型青光眼由于其患病率和长期性,仍然是一个高度的医疗保健问题。就药物处方制定治疗指南而言,抗青光眼药物治疗的现实世界需要定期审核。印度很少有研究在这方面采取纵向方法。进行这项研究以鉴定这种缺陷。方法:这是一项开放性,前瞻性,观察性研究。每位未接受过治疗的患者均接受了为期6个月的随访,其中扫描了他们的处方,以了解抗青光眼药物的类型,药物总数,给药途径,使用时间,用药频率和药物变化如果有的话,每次访问。结果:观察到从单一疗法向联合疗法的逐渐转变。处方的总体平均水平最高的是单一疗法,最高为44.25,然后是固定剂量组合,最高为38.25,然后是联合多药疗法,最高为36,而处方数最少的是同时疗法,为17.5。在所有单一疗法药物中,β受体阻滞剂是基线时最常用的处方药,但在我们的研究结束时,它们的处方份额几乎减半。另一方面,前列腺素类似物从其基线到本研究结束时处方数量激增。固定剂量组合的前列腺素类似物和β受体阻滞剂在整个研究期间一直是受欢迎的处方。结论:研究得出结论,从最初的单一疗法转向固定剂量组合的处方趋势显着。 β受体阻滞剂处方数量的减少和前列腺素类似物处方的增加证明了它们具有更好的疗效和耐受性。开角型青光眼药物治疗的未来在于以单一疗法或固定组合开出更有效的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号